These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7597026)

  • 1. Why can't cytotoxic T cells handle HIV?
    Bevan MJ; Braciale TJ
    Proc Natl Acad Sci U S A; 1995 Jun; 92(13):5765-7. PubMed ID: 7597026
    [No Abstract]   [Full Text] [Related]  

  • 2. Why can't the immune system control HIV-1? Defining HIV-1-specific CD4+ T cell immunity in order to develop strategies to enhance viral immunity.
    Ostrowski MA; Yu Q; Yue FY; Liu J; Jones B; Gu XX; Loutfy M; Kovacs CM; Halpenny R
    Immunol Res; 2006; 35(1-2):89-102. PubMed ID: 17003512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AIDS pathogenesis: a finite immune response to blame?
    Miedema F; Klein MR
    Science; 1996 Apr; 272(5261):505-6. PubMed ID: 8614796
    [No Abstract]   [Full Text] [Related]  

  • 4. HIV-specific cytotoxic T lymphocytes and their possible implications in the future vaccine against AIDS.
    Langlade-Demoyen P; Hoffenbach A
    Res Immunol; 1989 Jan; 140(1):95-9; discussion 119-20. PubMed ID: 2567045
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cytotoxic T cells against HIV].
    Autran B; Debré P
    Presse Med; 1990 Sep; 19(31):1435-7. PubMed ID: 1700412
    [No Abstract]   [Full Text] [Related]  

  • 6. Dual function of a human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte clone: inhibition of HIV replication by noncytolytic mechanisms and lysis of HIV-infected CD4+ cells.
    Buseyne F; Février M; Garcia S; Gougeon ML; Rivière Y
    Virology; 1996 Nov; 225(1):248-53. PubMed ID: 8918556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell strategies in AIDS vaccines: MHC-restricted T-cell responses to HIV proteins.
    Mills KH; Nixon DF; McMichael AJ
    AIDS; 1989; 3 Suppl 1():S101-10. PubMed ID: 2575396
    [No Abstract]   [Full Text] [Related]  

  • 8. The challenge of immune control of immunodeficiency virus.
    Richman D
    J Clin Invest; 1999 Sep; 104(6):677-8. PubMed ID: 10491402
    [No Abstract]   [Full Text] [Related]  

  • 9. HIV-peplotion vaccine. A novel approach to vaccination against AIDS by transepithelial transport of viral peptides and antigens to Langerhans cells for induction of cytolytic T cells by HLA class I and CD1 molecules for long term protection.
    Becker Y
    Adv Exp Med Biol; 1996; 397():97-104. PubMed ID: 8718588
    [No Abstract]   [Full Text] [Related]  

  • 10. Induction of a MHC class I-restricted, CD8 positive cytolytic T-cell response by chimeric HIV-1 virus-like particles in vivo: implications on HIV vaccine development.
    Wagner R; Deml L; Schirmbeck R; Reimann J; Wolf H
    Behring Inst Mitt; 1994 Dec; (95):23-34. PubMed ID: 7755506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine-elicited memory cytotoxic T lymphocytes contribute to Mamu-A*01-associated control of simian/human immunodeficiency virus 89.6P replication in rhesus monkeys.
    Seaman MS; Santra S; Newberg MH; Philippon V; Manson K; Xu L; Gelman RS; Panicali D; Mascola JR; Nabel GJ; Letvin NL
    J Virol; 2005 Apr; 79(8):4580-8. PubMed ID: 15795244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AIDS. Virological mayhem.
    Wain-Hobson S
    Nature; 1995 Jan; 373(6510):102. PubMed ID: 7816085
    [No Abstract]   [Full Text] [Related]  

  • 13. The lucky ones. How do some HIV-positive people avoid getting AIDS?
    Beardsley T
    Sci Am; 1994 May; 270(5):20, 24, 28. PubMed ID: 7910979
    [No Abstract]   [Full Text] [Related]  

  • 14. AIDS and Trojan horses.
    Elder D; Harris R
    Riv Biol; 1992; 85(2):247-8. PubMed ID: 1361074
    [No Abstract]   [Full Text] [Related]  

  • 15. T-cell-mediated immunopathology versus direct cytolysis by virus: implications for HIV and AIDS.
    Zinkernagel RM; Hengartner H
    Immunol Today; 1994 Jun; 15(6):262-8. PubMed ID: 7915115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive loss of IL-2-expandable HIV-1-specific cytotoxic T lymphocytes during asymptomatic HIV infection.
    Jin X; Wills M; Sissons JG; Carmichael A
    Eur J Immunol; 1998 Nov; 28(11):3564-76. PubMed ID: 9842899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV type 1 abrogates TAP-mediated transport of antigenic peptides presented by MHC class I. Transporter associated with antigen presentation.
    Kutsch O; Vey T; Kerkau T; Hünig T; Schimpl A
    AIDS Res Hum Retroviruses; 2002 Nov; 18(17):1319-25. PubMed ID: 12487820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The majority of currently circulating human immunodeficiency virus type 1 clade B viruses fail to prime cytotoxic T-lymphocyte responses against an otherwise immunodominant HLA-A2-restricted epitope: implications for vaccine design.
    Altfeld M; Allen TM; Kalife ET; Frahm N; Addo MM; Mothe BR; Rathod A; Reyor LL; Harlow J; Yu XG; Perkins B; Robinson LK; Sidney J; Alter G; Lichterfeld M; Sette A; Rosenberg ES; Goulder PJ; Brander C; Walker BD
    J Virol; 2005 Apr; 79(8):5000-5. PubMed ID: 15795285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [[Research Progress in Escape Mutations of the Human Immunodeficiency Virus under Pressure of HLA-Restricted Cytotoxic T Lymphocytes].
    Shi Y; Wan Y; Xu J
    Bing Du Xue Bao; 2015 May; 31(3):299-306. PubMed ID: 26470538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV evolution and progression of the infection to AIDS.
    Huang G; Takeuchi Y; Korobeinikov A
    J Theor Biol; 2012 Aug; 307():149-59. PubMed ID: 22634206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.